Uroxatral (alfuzosin hcl) is an alpha blocker prescribed to treat symptoms of an enlarged prostate ( benign prostatic hyperplasia ), which include
Alfuzosin hydrochloride has been found to be a safe and effective when administered at the therapeutic dose (10 mg once-daily) to patients over
5 mg immediate-release formulation (administered three times daily) was developed; afterwards, a 5 mg (administered twice daily) sustained-release formulation was produced
Maintenance dose: Initial dose may be increased as needed and appropriate in a stepwise fashion to 2, 5, or 10 mg orally once a day
Ureteral stones, expulsion (off-label use): Oral: 10 mg once daily, discontinue after successful expulsion (average time to expulsion 1-2 weeks) (Agrawal, 2009; Ahmed, 2010; Gurbuz, 2011)
5 mg twice daily adjusted according to clinical response
4 mg orally once a day; the dose may be increased to 0
BPH [10 mg PO qd] Info: give w/ food; do not cut/crush/chew tab contraindicated w/in 14 days of daily mifepristone use: combo may incr
A 10 mg injection dose is predicted to provide pharmacological effect equivalent to the 20 mg oral dose
is recommended that therapy should commence with a single dose of Alfuzosin HCl 2
Dogs: 0
5 mg three times a day; maximum 10 mg a day
Therefore, alfuzosin hydrochloride should be taken with food and with the same meal each day
If this daily dosage doesn’t work well enough to treat your ED, your doctor may Usual Adult Dose for Benign Prostatic Hyperplasia: 0
5 mg to 30 mg, and in patients with BPH at doses from 7
Some patients with Zollinger-Ellison Syndrome have been treated for longer than 5 years
Alfuzosin 10 mg should not be given to patients with severely impaired renal function (creatinine clearance < 30 ml/min) as there are no clinical safety data available for this patient group (see section 4
Nonmedicinal ingredients: colloidal hydrated silica, The usual recommended dose is one 10 mg tablet daily, after a meal